Description of a new biosafe procedure for cytological specimens from patients with COVID-19 processed by liquid-based preparations.
Patrizia StracciaEsther Diana RossiMaurizio MartiniAntonino MulèFederica CianfriniMariangela CuratoloAlessandra CancellieriChiara BrunelliGian Franco ZannoniGuido FaddaPublished in: Cancer cytopathology (2020)
Despite some minor changes in the morphology of the cells, the results of this study highlight that the adoption of the new protocol for the biosafety of LBC-processed samples in pathology laboratories is important for minimizing the risk for personnel, trainees, and cytopathologists without impairing the diagnostic efficacy of the technique.